Suppr超能文献

脂质体疫苗的设计考虑因素:配方参数对与脂质体相关抗原结合的抗体和细胞介导免疫应答的影响。

Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

机构信息

Biosciences Division, SRI International, 140 Research Drive, Harrisonburg, VA 22802, United States.

出版信息

Vaccine. 2012 Mar 16;30(13):2256-72. doi: 10.1016/j.vaccine.2012.01.070. Epub 2012 Feb 2.

Abstract

Liposomes (phospholipid bilayer vesicles) are versatile and robust delivery systems for induction of antibody and T lymphocyte responses to associated subunit antigens. In the last 15 years, liposome vaccine technology has matured and now several vaccines containing liposome-based adjuvants have been approved for human use or have reached late stages of clinical evaluation. Given the intensifying interest in liposome-based vaccines, it is important to understand precisely how liposomes interact with the immune system and stimulate immunity. It has become clear that the physicochemical properties of liposomal vaccines - method of antigen attachment, lipid composition, bilayer fluidity, particle charge, and other properties - exert dramatic effects on the resulting immune response. Here, we present a comprehensive review of the physicochemical properties of liposomal vaccines and how they influence immune responses. A discussion of novel and emerging immunomodulators that are suitable for inclusion in liposomal vaccines is also presented. Through a comprehensive analysis of the body of liposomal vaccine literature, we enumerate a series of principles that can guide the rational design of liposomal vaccines to elicit immune responses of a desired magnitude and quality. We also identify major unanswered questions in the field, pointing the direction for future study.

摘要

脂质体(磷脂双层囊泡)是诱导抗体和 T 淋巴细胞对相关亚单位抗原反应的多功能且稳健的递药系统。在过去的 15 年中,脂质体疫苗技术已经成熟,现在已经有几种包含基于脂质体的佐剂的疫苗被批准用于人体使用或已进入临床评估的后期阶段。鉴于人们对基于脂质体的疫苗的兴趣日益浓厚,了解脂质体与免疫系统的相互作用以及刺激免疫的机制非常重要。很明显,脂质体疫苗的物理化学特性——抗原附着的方法、脂质组成、双层流动性、颗粒电荷和其他特性——对产生的免疫反应有显著影响。在这里,我们全面回顾了脂质体疫苗的物理化学特性以及它们如何影响免疫反应。还讨论了适合包含在脂质体疫苗中的新型和新兴免疫调节剂。通过对脂质体疫苗文献的全面分析,我们列举了一系列原则,可以指导脂质体疫苗的合理设计,以产生所需大小和质量的免疫反应。我们还确定了该领域的主要未解决问题,为未来的研究指明了方向。

相似文献

2
Liposomal vaccine delivery systems.
Expert Opin Drug Deliv. 2011 Apr;8(4):505-19. doi: 10.1517/17425247.2011.558081. Epub 2011 Mar 18.
3
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines.
J Nanobiotechnology. 2017 Nov 17;15(1):83. doi: 10.1186/s12951-017-0319-9.
4
Designing liposomal adjuvants for the next generation of vaccines.
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):85-96. doi: 10.1016/j.addr.2015.11.005. Epub 2015 Nov 11.
5
Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.
J Pharm Sci. 1996 Dec;85(12):1286-9. doi: 10.1021/js9601593.
6
Liposomal presentation of antigens for human vaccines.
Pharm Biotechnol. 1995;6:325-45. doi: 10.1007/978-1-4615-1823-5_13.
9
Liposomes as vaccine delivery systems: a review of the recent advances.
Ther Adv Vaccines. 2014 Nov;2(6):159-82. doi: 10.1177/2051013614541440.
10
Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
Int J Pharm. 2008 Dec 8;364(2):272-80. doi: 10.1016/j.ijpharm.2008.04.036. Epub 2008 Apr 30.

引用本文的文献

1
Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations.
Front Immunol. 2025 May 14;16:1584876. doi: 10.3389/fimmu.2025.1584876. eCollection 2025.
6
Therapeutic ultrasound: an innovative approach for targeting neurological disorders affecting the basal ganglia.
Front Neuroanat. 2024 Oct 2;18:1469250. doi: 10.3389/fnana.2024.1469250. eCollection 2024.
7
An Integrated Signaling Threshold Initiates IgG Response toward Virus-like Immunogens.
J Immunol. 2024 Oct 15;213(8):1061-1075. doi: 10.4049/jimmunol.2400101.
8
Building a Simplistic Automatic Extruder: Instrument Development Opportunities for the Laboratory.
J Chem Educ. 2024 Aug 1;101(8):3292-3300. doi: 10.1021/acs.jchemed.4c00287. eCollection 2024 Aug 13.
10
Nanoparticle-neutrophils interactions for autoimmune regulation.
Adv Drug Deliv Rev. 2024 Jun;209:115316. doi: 10.1016/j.addr.2024.115316. Epub 2024 Apr 23.

本文引用的文献

1
Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses.
J Control Release. 2012 Feb 28;158(1):72-7. doi: 10.1016/j.jconrel.2011.10.012. Epub 2011 Oct 18.
2
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
N Engl J Med. 2011 Nov 17;365(20):1863-75. doi: 10.1056/NEJMoa1102287. Epub 2011 Oct 18.
3
CAF01 potentiates immune responses and efficacy of an inactivated influenza vaccine in ferrets.
PLoS One. 2011;6(8):e22891. doi: 10.1371/journal.pone.0022891. Epub 2011 Aug 5.
5
The RTS,S vaccine candidate for malaria.
Expert Rev Vaccines. 2011 May;10(5):589-99. doi: 10.1586/erv.11.57.
6
Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems.
Expert Rev Vaccines. 2011 Apr;10(4):471-86. doi: 10.1586/erv.11.29.
7
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling.
Nat Immunol. 2011 May;12(5):408-15. doi: 10.1038/ni.2022. Epub 2011 Apr 10.
8
Liposomal vaccine delivery systems.
Expert Opin Drug Deliv. 2011 Apr;8(4):505-19. doi: 10.1517/17425247.2011.558081. Epub 2011 Mar 18.
9
Programming the magnitude and persistence of antibody responses with innate immunity.
Nature. 2011 Feb 24;470(7335):543-7. doi: 10.1038/nature09737.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验